Penumbra, Inc., a global healthcare company focused on innovative therapies, announced the first patient enrolled in STORM-PE, a first-of-its-kind prospective, multi-center, randomized controlled trial...
Leidos, a Fortune 500® science and technology company, announced it was recently awarded a new $32 million contract by the Marine Corps System Command (MARCORSYSCOM) through...
Synopsys, Inc. announced the expansion of its leading Synopsys.ai™ EDA suite, to bring the power of generative artificial intelligence (GenAI) across the full stack...
Clinical research often lacks sufficient evidence, leading to prescribing decisions in healthcare that are not evidence-based or supported by randomized, double-blind clinical trials. This...
